Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.

Yamane, Yuki; Shiono, Ayako; Ishii, Yoshiki; Isobe, Kazutoshi; Miyauchi, Eisaku; Kishi, Kazuma; Nishino, Makoto; Sugawara, Shunichi; Ko, Ryo; Koyama, Nobuyuki; Yabuki, Yutaka; Kobayashi, Kunihiko

Yamane, Yuki; Shiono, Ayako; Ishii, Yoshiki; Isobe, Kazutoshi; Miyauchi, Eisaku; Kishi, Kazuma; Nishino, Makoto; Sugawara, Shunichi; Ko, Ryo; Koyama, Nobuyuki; Yabuki, Yutaka; Kobayashi, Kunihiko.

Afiliación

Yamane Y; Department of Thoracic Oncology, Saitama Cancer Center, Saitama.
Shiono A; Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama.
Ishii Y; Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Tochigi.
Isobe K; Division of Respiratory Medicine, Toho University Omori Medical Center, Tokyo.
Miyauchi E; Department of Respiratory Medicine, Tohoku University Hospital, Miyagi.
Kishi K; Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo.
Nishino M; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo.
Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi.
Ko R; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo.
Koyama N; Division of Pulmonary Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, Saitama.
Yabuki Y; AstraZeneca K.K. , Japan.
Kobayashi K; Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama kobakuni@saitama-med.ac.jp.

Jpn J Clin Oncol ; 46(12): 1135-1142, 2016 Dec.

Article en En | MEDLINE | ID: mdl-27655904

Asunto(s)

Antineoplásicos/uso terapéutico; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Receptores ErbB/genética; Neoplasias Pulmonares/tratamiento farmacológico; Adulto; Anciano; Anciano de 80 o más Años; Inhibidores de la Angiogénesis/uso terapéutico; Bevacizumab/uso terapéutico; Carcinoma de Pulmón de Células no Pequeñas/mortalidad; Carcinoma de Pulmón de Células no Pequeñas/patología; Resistencia a Antineoplásicos/efectos de los fármacos; Quimioterapia Combinada; Femenino; Humanos; Japón; Neoplasias Pulmonares/mortalidad; Neoplasias Pulmonares/patología; Masculino; Persona de Mediana Edad; Mutación; Recurrencia Local de Neoplasia; Estudios Retrospectivos; Tasa de Supervivencia; Resultado del Tratamiento

Palabras clave

T790M mutation; epidermal growth factor receptor; non-small-cell lung cancer; retrospective studies; treatment outcome

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Receptores ErbB / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Jpn J Clin Oncol Año: 2016 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links